AUC24 < 80 (n=31) |
AUC24
< 80 (n=31) |
Developed AKI, n (%) |
14 (45.2) |
Did NOT Develop AKI, n (%) |
17 (54.8) |
AUC24 ≥ 80 (n=120) |
AUC24 ≥ 80
(n=120) |
Developed AKI, n (%) |
34 (28.3) |
Did NOT Develop AKI, n (%) |
86 (71.7) |
Pearson Chi-Square 2-sided significance: p=0.147 |
Pearson Chi-Square
2-sided significance: p=0.147 |
Cmax < 8-fold the highest PsA MIC (n=77) |
Cmax < 8-fold the highest PsA MIC
(n=77) |
Developed AKI, n (%) |
28 (36.4) |
Did NOT Develop AKI, n (%) |
49 (63.6) |
Cmax ≥ 8-fold the highest PsA MIC (n=74) |
Cmax ≥ 8-fold the highest PsA MIC (n=74) |
Developed AKI, n (%) |
20 (27) |
Did NOT Develop AKI, n (%) |
54 (73) |
Pearson Chi-Square 2-sided significance: p=0.218 |
Pearson Chi-Square
2-sided significance: p=0.218 |